Dantrolene Sodium Salt: High-Purity Ryanodine Receptor Antagonist for Advanced Calcium Modulation and Gene Editing

Executive Summary: Dantrolene sodium salt (SKU B6329, APExBIO) is a potent and selective inhibitor of ryanodine receptor (RyR) calcium channels, with an IC50 of 5.9 ± 0.3 nM for RyR2 (source: product_spec). Its calmodulin-dependent action enables precise inhibition of pathological intracellular calcium release, implicated in acute and chronic disease models (source: Nature Communications). Dantrolene sodium salt demonstrates efficacy in modulating cell viability, reducing enzyme activity in pancreatitis, and supporting high-fidelity genome editing by influencing DNA repair pathway choice (source: beclometasonelab.com). The compound is supplied at >98% purity, with validated HPLC and NMR data, and is recommended for short-term solution use at room temperature (source: product_spec).

Biological Rationale

Dantrolene sodium salt is a benchmark pharmacological tool for studying ryanodine receptor (RyR) biology. RyRs are intracellular calcium release channels located on the membranes of the endoplasmic and sarcoplasmic reticulum. These channels regulate cytosolic calcium concentration, which is essential for muscle contraction, neuronal excitability, and cell survival (source: corticostatin.com). Dysregulation of RyR-mediated calcium release has been linked to ischemia, hypoxia, anesthesia-induced complications, trauma, seizures, and neurodegenerative diseases. Precise pharmacological inhibition of RyRs is therefore critical for dissecting disease mechanisms and validating therapeutic targets (source: product_spec).

Mechanism of Action of Dantrolene, sodium salt

Dantrolene sodium salt acts as a selective and potent inhibitor of ryanodine receptors, especially RyR2, with reported IC50 values of 5.9 ± 0.3 nM in purified mouse cardiomyocyte systems (source: product_spec). The inhibitory effect is calmodulin-dependent: dantrolene reduces calcium wave frequency and amplitude only in the presence of calmodulin, indicating a requirement for this cofactor in its mechanism (source: corticostatin.com). This property distinguishes dantrolene sodium salt from non-specific calcium channel blockers and underpins its utility in models requiring precise modulation of intracellular calcium dynamics.

Evidence & Benchmarks

• Dantrolene sodium salt inhibits RyR2 channel activity with an IC50 of 5.9 ± 0.3 nM under calmodulin-present conditions (source: product_spec).
• In mouse models of caerulein-induced pancreatitis, dantrolene administration reduced pancreatic trypsin activity and cellular damage, supporting its role as a pancreatitis research compound (source: product_spec).
• Dantrolene sodium salt modulates DNA double-strand break (DSB) repair pathway choice in human induced pluripotent stem cells, impacting the balance between non-homologous end joining (NHEJ), microhomology-mediated end joining (MMEJ), and homology-directed repair (HDR) during CRISPR editing (source: Nature Communications).
• In gene-editing assays, dantrolene sodium salt enhances reproducibility and specificity by minimizing RyR-mediated calcium fluctuations, as detailed in validated laboratory workflows (source: calpaininhibitorii.com).
• The compound is insoluble in water and ethanol, but soluble in DMSO at concentrations ≥12.2 mg/mL, facilitating preparation for in vitro and ex vivo assays (source: product_spec).

For a broader overview of protocol-driven applications, see Dantrolene Sodium Salt: Precision Modulation of DNA Repair and Calcium Signaling, which focuses on maximizing assay specificity, while this article emphasizes comparative benchmarks and mechanistic clarity.

To compare troubleshooting strategies for RyR antagonists, this guide details actionable optimizations, complementing the present article's emphasis on evidence synthesis and workflow integration.

Applications, Limits & Misconceptions

Dantrolene sodium salt is validated for applications in calcium signaling modulation, neurodegenerative disease models, ischemia and hypoxia research, pancreatitis research, and genome editing. By controlling RyR-mediated calcium release, it is used to dissect calcium-dependent cellular processes and to improve reproducibility in CRISPR and synthetic lethality assays (source: calpain-inhibitor-i.com).

Common Pitfalls or Misconceptions

• Not a non-specific calcium channel blocker: Dantrolene sodium salt selectively inhibits RyRs and does not block voltage-gated calcium channels or store-operated calcium entry (source: beclometasonelab.com).
• Requires calmodulin for efficacy: Its RyR2 inhibition is calmodulin-dependent and ineffective in the absence of this cofactor (source: corticostatin.com).
• Short-term solution stability: Dantrolene sodium salt solutions should be used promptly after preparation to avoid degradation and loss of activity (source: product_spec).
• Not suitable for aqueous-only protocols: The compound is insoluble in water and ethanol, requiring DMSO or other compatible solvents (source: product_spec).
• Does not directly repair DNA: Dantrolene modulates the cellular environment to influence DNA repair pathway choice, but does not itself act as a DNA repair enzyme (source: Nature Communications).

Workflow Integration & Parameters

Dantrolene sodium salt (B6329, APExBIO) is supplied at high purity (>98%), accompanied by HPLC and NMR quality control data. It is recommended for short-term storage at room temperature, with freshly prepared DMSO solutions for experimental use (source: product_spec).

Protocol Parameters

• RyR inhibition assay | 5.9 ± 0.3 nM (IC50) | Cardiomyocyte/skeletal muscle models | Benchmark for nanomolar potency and selectivity in RyR2 inhibition | product_spec
• Calcium wave assay | 10–20 nM working concentration | Neuronal/cardiomyocyte cultures | Validated for calmodulin-dependent calcium signaling modulation | workflow_recommendation
• CRISPR gene editing support | 0.1–1 µM | hiPSC and genome editing workflows | Minimizes off-target calcium-mediated cell stress during DSB repair | workflow_recommendation
• Pancreatitis model | 5–20 mg/kg (in vivo) | Mouse models | Demonstrated reduction in pancreatic trypsin activity and tissue damage | product_spec
• Solubility prep | ≥12.2 mg/mL in DMSO | All in vitro assays | Ensures complete dissolution; avoid water/ethanol | product_spec

Conclusion & Outlook

Dantrolene sodium salt is a validated ryanodine receptor antagonist with robust performance in calcium signaling, pancreatitis, and genome editing research. Its calmodulin-dependent mechanism, nanomolar potency, and high purity make it the preferred compound for precise modulation of intracellular calcium release (source: product_spec). As demonstrated in recent high-throughput drug repurposing efforts, dantrolene sodium salt enables more controlled DNA repair pathway selection and enhances reproducibility in CRISPR-based assays (source: Nature Communications). Future directions include further protocol optimization for disease modeling and synthetic lethality applications, leveraging APExBIO's rigorous quality standard and expanding on established workflows (source: calpaininhibitorii.com).